Seventh Valmet Supplied Tissue Line Successfully Started up at Hengan's mill in China

Valmet and Hengan joined forces on January 15, 2018, to successfully start a Valmet Advantage DCT 200 tissue line at Hengan's mill in Weifang, China. 

PM 21 is the third of four Advantage DCT 200 lines recently ordered by Hengan. When the startup of PM 22 takes place at the same mill in Weifang later this year, Hengan will have a total of eight Valmet supplied tissue production lines in operation. The other two Advantage DCT 200 machines were started in Wuhu, China, with excellent results in 2016. All three startups have been well coordinated and performed in record time, which creates a great outlook for the upcoming PM22 premiere. 

The investments support Hengan's aim of strengthening their leading market position in China, while the well proven Advantage DCT Technology ensures a stable production of high-quality tissue, in this case mainly used for facial, toilet and towel grades.

 

Hengan is China's leading tissue producer, with a current tissue production exceeding one million tons per year. The high-performance Advantage DCT 200 trio counts for a capacity of least 180,000 tpy of tissue products, soon to be 240,000 tpy once all four production lines are started and optimized.